DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dalteparin sodium
Dalteparin sodium
Thromboprophylaxis for Venous Thromboembolism UHL Guideline
Hemosil ® Liquid Anti-Xa
The Management of Anticoagulants Using the Chart: – Low Molecular Weight Heparins (I.E
Dalteparin Sodium Injection) in Children with Venous Thromboembolism with Or Without Malignancies
Perioperative Management of Patients Treated with Antithrombotics in Oral Surgery
Estonian Statistics on Medicines 2016 1/41
Antithrombotic Therapy During Pregnancy
Fragmin Injection (Dalteparin Sodium)
Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes
Review of Medical Therapies for the Management of Pulmonary Embolism
Estonian Statistics on Medicines 2013 1/44
Utah Medicaid Pharmacy and Therapeutics Committee Drug
Fragmin) Reference Number: ERX.SPA.207 Effective Date: 01.11.17 Last Review Date: 02.21 Revision Log Line of Business: Commercial, Medicaid
Fragmin ®) SMC No
Fragmin® Graduated Syringe
NCCN Guidelines ®
Pharmacology of Anticoagulants Used in the Treatment of Venous Thromboembolism
Australian Public Assessment Report for Dalteparin
Top View
NDA/BLA Multi-Disciplinary Review and Evaluation
Endovascular Pharmacology Chart
Cross Discipline Team Leader Review
Dalteparin: Pharmacological Properties and Clinical Efficacy in the Prophylaxis and Treatment of Thromboembolic Diseases
CV185-444 Mcbane Amendment 3
Dalteparin Sodium in the Management of Thromboembolic Disorders
6 Using Low-Molecular-Weight Heparin in Infants and Children
Dalteparin (Fragmin) Reference Number: CP.PHAR.225 Effective Date: 05/16 Coding Implications Last Review Date: 05/17 Revision Log
What You Should Know About Fragmin
Edoxaban: a Comprehensive Review of the Pharmacology and Clinical Data for the Management of Atrial Fibrillation and Venous Thromboembolism
Journal of Chromatography A, 1479 (2017) 121–128
(VTE) V.1.2018 – Follow-Up on 03/12/18
Fondaparinux), Lovenox® (Enoxaparin), Fragmin® (Dalteparin
Australian Statistics on Medicines 2009
Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Imaging Guided Interventions: Body Imaging Division
Comparison of the Oral Direct Thrombin Inhibitor
Resource Impact Report: Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing (NG158)
FRAGMIN® (Dalteparin Sodium) Injection, for Subcutaneous Use Patients Initial U.S
Reactions 1244 - 21 Mar 2009 1
Neuraxial Blockade and Anticoagulation
DALTEPARIN SODIUM Class: Low Molecular Weight Heparin
Cdr Clinical Review Report for Lixiana
Low Molecular Weight Heparins (Lmwhs)
1 FRAGMIN® Dalteparin Sodium Injection For
Trendsrx®Generic Launch Alert Enoxaparin Sodium Injection (Lovenox®)*
Rivaroxaban for the Treatment of Deep Vein Thrombosis and Secondary Prevention of Venous Thromboembolism
Product Monograph
Anticoagulants
Low-Molecular-Weight Heparin As Bridging Anticoagulation During Interruption of Warfarin Assessment of a Standardized Periprocedural Anticoagulation Regimen
Steroid Injections
Anticoagulation Therapy in Selected Cancer Patients at Risk of Recurrence of Venous Thromboembolism
CP.PHAR.225 Effective Date: 05.01.16 Last Review Date: 02.21 Coding Implications Line of Business: Commercial, HIM*, Medicaid Revision Log
Effectiveness of a Guideline for Venous
Product Monograph
Supplementary Data
Clinical Policy: Dalteparin (Fragmin)
Pr FRAGMIN® (Dalteparin Sodium Injection)
Dosage Forms and Strengths
Melagatran for Thromboprophylaxis After Mechanical Valve Implantation: Results in a Heterotopic Porcine Model
A Randomized Trial Comparing 2 Low-Molecular- Weight Heparins for the Outpatient Treatment of Deep Vein Thrombosis and Pulmonary Embolism
Dalteparin (Fragmin) Reference Number: PA.CP.PHAR.225 Effective Date: 01/18 Coding Implications Last Review Date: 07/18 Revision Log
Published Version
Anticoagulants and the Management of Coagulopathy
Medications in Dermatology, Part 3: Dr
Comparison of Clinical Results in Deep Vein Thrombosis of Total Knee Arthroplasty with Rivaroxaban and Dalteparin Sodium